Aetiological factors in development of myasthenia gravis.
Vincent
A
A
Department of Clinical Neurology, University of Oxford, UK.
D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D000938:Antigen-Presenting Cells / Q000276:immunology; D002648:Child; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology; D006801:Humans; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000145:classification / Q000209:etiology* / Q000473:pathology; D011978:Receptors, Nicotinic / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D013950:Thymus Gland / Q000473:pathology
D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II; D011978:Receptors, Nicotinic